Carlos H. Barrios, Sara A. Hurvitz, Sara M. Tolaney, Javier Cortés, Kevin Punie, Andreas Schneeweiss, Adam Brufsky, Mafalda Oliveira, Joohyuk Sohn, Eriko Tokunaga, Alessandra Fabi, Yeon Hee Park, Binghe Xu, Roberto Hegg, Meghna Das Thakur, Yajia Zhang, Natalya Vaksman, Catherine Lai, Aditya Bardia. "ASCENT-03: Efficacy by biomarker subgroup with sacituzumab govitecan (SG) vs chemotherapy (chemo) in participants (pts) with previously untreated advanced triple-negative breast cancer (TNBC) who are not candidates for PD-(L)1 inhibitors (PD-[L]1i).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.1014